Got to listen this to it this morning. Around 1, fda has responded and they plan on meeting to finalize trial design. Great news. If that is the discussion, looks like the fda reviewed it and is going to approve after some tweeks to trial design. I wonder if they might switch from all on 700mg at the beginning to random 525 vs 700mg the entire trial, which would give better data in induction part in my opinion. I’ll be gone most of today, I’ll miss the presentation, but will try to listen either tonight or tomorrow morning. I’ll check comments here as well.